Recalls from Roche Diagnostics Operations, Inc.

• Cobas Pro Integrated Solutions with Cobas C 503 analytical Units (opens in a new tab)
  Moderate risk, FDA, Feb 27, 2026, Software defect
• Roche Diagnostics Elecsys Anti-TSHR Immunoassay (opens in a new tab)
  Moderate risk, FDA, Jan 2, 2026, Device defect

Data: Recall Canary (opens in a new tab)